Orphapacket:
  ORPHApacketId: '94'
  creationDate: '2020-06-27 22:10:58'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '94'
  Label: Astrocytoma
  PURL: http://www.orpha.net/ORDO/Orphanet_94
  DisorderType:
    value: Clinical group
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
  Synonyms:
  - Synonym: Astrocytic tumor
  ExternalReferences:
  - Source: OMIM
    Reference: '137800'
    DisorderMappingRelation: NTBT (ORPHA code's Narrower Term maps to a Broader Term)
  TextSection:
    TextSectionType: Definition
    Contents: A complex group of benign and malignant cerebral tumors arising at any
      age.
  Parents:
  - Parent:
    - ORPHAcode: '182067'
      Label: Glial tumor
  Childs:
  - Child:
      Label: High-grade astrocytoma
      ORPHAcode: '251561'
      Genes: no data
  - Child:
      Label: Low-grade astrocytoma
      ORPHAcode: '251592'
      Genes: no data
  Prevalences:
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]_
        ORPHANET
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Austria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Belgium
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Bulgaria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Croatia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Czech Republic
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Estonia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Germany
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Iceland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Latvia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Lithuania
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Malta
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Poland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Portugal
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Slovakia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Slovenia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Switzerland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Netherlands
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: any age
